Drug Shortage Report for KETAMINE HYDROCHLORIDE INJECTION USP

Last updated on 2023-11-23 History
Report ID 204614
Drug Identification Number 02246796
Brand name KETAMINE HYDROCHLORIDE INJECTION USP
Common or Proper name KETAMINE HCL
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) KETAMINE
Strength(s) 50MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 10ML 1LIVI
ATC code N01AX
ATC description ANESTHETICS, GENERAL
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date 2023-11-20
Actual start date
Estimated end date 2023-12-18
Actual end date 2023-11-22
Shortage status Resolved
Updated date 2023-11-23
Company comments Product is available on allocation at wholesalers, based on 100% of historical volumes.
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2023-11-23 English Compare
v5 2023-11-22 French Compare
v4 2023-11-22 English Compare
v3 2023-11-21 English Compare
v2 2023-09-18 French Compare
v1 2023-09-18 English Compare

Showing 1 to 6 of 6